Publication | Closed Access

Design and synthesis of novel diosgenin-triazole hybrids targeting inflammation as potential neuroprotective agents

InflammationAnti-inflammatoryPotential Neuroprotective AgentsMedicineDrug DiscoveryImmunologyPharmacological AgentPharmacologyNovel Diosgenin-triazole Hybrids